WO2005075017A1 - An improved percutaneous lead - Google Patents
An improved percutaneous lead Download PDFInfo
- Publication number
- WO2005075017A1 WO2005075017A1 PCT/AU2005/000135 AU2005000135W WO2005075017A1 WO 2005075017 A1 WO2005075017 A1 WO 2005075017A1 AU 2005000135 W AU2005000135 W AU 2005000135W WO 2005075017 A1 WO2005075017 A1 WO 2005075017A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- lead
- lead assembly
- hole
- percutaneous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0504—Subcutaneous electrodes
Definitions
- the present invention relates to an improved percutaneous lead and improved means of implanting said lead for use with implantable medical devices.
- implantable medical assist devices passively assist patient's body functions. Examples of passive medical devices include: artificial cannulation to replace or assist failing arteries or veins; and various artificial implants such as artificial blood implants. Other implantable medical devices are called active implantable medical devices. These active implantable medical devices generally require a power source or supply to function or aid the patient's normal bodily functions. These active implantable medical devices may include pacemakers, implantable pumps, neuro-stimulators, and cochlear implants. There has been a long felt need to be able to safely and reliably implant active medical assist devices and to avoid long term patient problems associated with the use of such devices.
- One of the common problems encountered with the use of these devices is that a substantial proportion of these generally require a means of communicating electrical information, data, and/or power with the external environment outside the body of a patient, when implanted.
- the traditional solution for this problem is to connect the implanted active medical device to a percutaneous lead.
- This lead preferably extends from the implanted device within the patient's body, through the skin layer of a patient then to a controller, computer or power circuit (external to the patient's body).
- This traditional configuration may lead to increased risk of bacterial infection and reduced quality of life for the patient. Additionally there is a risk that said lead may be accidentally severed by the patient and this raises safety and reliability concerns relating to the traditional use of percutaneous leads.
- the present invention in a broad form, provides a percutaneous lead assembly for supplying electrical signals to a medical device implanted within a body of a patient, said lead assembly comprising a flexible elongate member having a first portion adapted to remain external to the body of a patient, said first portion having a first diameter; and a second portion joined to said first portion and adapted to extend through a hole in a skin layer of the body of the patient, and wherein said second portion having a second diameter which is substantially smaller than said first diameter.
- said first portion may include a shielding layer. Additionally, at least a segment of said second portion may be covered with a textured surface.
- said first portion and said second portion may be joined by connectors and said percutaneous lead assembly may include a lead restraint.
- an external lead restraint for use with a percutaneous lead wherein said lead is implanted within a body of a patient and extends through a hole in the patient's skin and characterised in that an excess length of lead is releasably secured near to the hole by releasable securing means affixed to the patient's skin.
- a percutaneous lead assembly for supplying electrical signal to a medical device implanted within a body of a patient, wherein said lead assembly has a flexible elongate member including a first unshielded portion that extends through a hole in a skin layer of the body of the patient; and a second shielded portion which is joined to said first unshielded portion at a site external to the body of the patient.
- Figure 1 shows a schematic view of a first preferred embodiment of the present invention, in situ;
- Figure 2 shows a cut away side view of a portion of a preferred embodiment;
- Figure 3 shows a cut away side view of a portion of a preferred embodiment;
- Figure 4 shows a cross sectional side view of an embodiment;
- Figure 5 shows a top view of a preferred embodiment;
- Figure 6 shows a cross sectional side view of a portion of the strain terminator mechanism shown in figure 5.
- the present invention generally relates to an improvement to percutaneous lead assemblies.
- a first preferred embodiment of this invention is shown in Figure 1.
- a patient 1 is implanted with a medical assist device 2 to assist or enhance the patient's body function.
- this medical assist device may be active or passive and may require uni- or bi-directional data, instructions, and/or power in the form of electrical signals from the external environment.
- these electrical signals may be communicated by an external controller 7.
- the external controller 7 is in electrical communication with the implanted medical device 2 by the use of the flexible percutaneous lead assembly 10.
- the external controller 7 is or may include any of the following devices: batteries, power supply, hardware controller, personal computer, microcontroller, and/or microprocessors.
- the connection formed by the percutaneous lead assembly 10 may allow for the transmission and reception of electrical signals.
- the lead assembly 10 may allow for a continuous electrical link between the medical device 2 and the controlling device 7 by the use of continuous wiring (not shown in Figure 1) running through the core of the lead assembly 10.
- the lead assembly 10 extends from the medical device 2, implanted within the body of the patient 1, through a hole or aperture 5, made by a physician or doctor, to the controlling device 7.
- the preferred percutaneous lead assembly 10 may also include: two ends, two connectors 3 & 9, wherein one connecter is connected to either end of the lead assembly 10 and wherein preferably each connector 3 & 9 is designed to mate with a respective corresponding connector on the medical device 2 and/or the controlling device 7.
- the percutaneous lead assembly 10 has a first portion 8 and a second portion 4.
- the second portion 4 may extend from the first connector 3 through the aperture 5 and join with the first portion 8.
- the section of the lead referred to as the second portion 4 may include regions coated with a textured surface.
- This textured surface may be produced by coating the region of the lead with velour or DacronTM. These types of coating materials promote ingrowth of the patient's cells into the surface of the textured surface and assist in anchoring lead assembly 10 within the patient's body 1. It is also preferred to only coating the lead portions, where necessary to achieve the desired amount of ingrowth or anchoring within the body 1.
- the second portion 4 extends out from the patient's body 1 through the hole 5. This extension past the hole 5 is shown by relatively thin region 6.
- region 6 does not include a textured coating.
- hole 5 may also be referred to as a permanent exit wound.
- the relatively thin region 6 is integrally joined to the relatively thick region of first portion 8.
- the first portion 8 is also joined to a connector
- the connector 9 When in use, the connector 9 may be connected to a controlling device 7.
- the second portion 4 passing through the exit wound 5 generally allows the exit wound to be of a substantially smaller diameter than otherwise would be the case if the lead assembly was of a uniform thickness. This reduction in the size of the exit wound may lessen the trauma experienced by patient 1 during and after implantation; as well as reducing the chance of infection at or near to the exit wound region.
- the relatively thick region of first portion 8 of the lead assembly 10 may allow for increased wear resistance of the external portion of the lead as well as providing extra shielding for the wiring within the assembly 10.
- the first portion 8 may be constructed by wrapping or coating the relatively thin regions that extend externally from the patient's body and effectively protect or reinforce the external portion of the lead assembly 10.
- a protective sheath may be used to the first portion 8 to achieve a similar effect of protecting the external portion of the wiring assembly.
- FIG. 2 depicts a cross sectional cut away view of the first portion 8 of lead assembly 10.
- the first portion 8 of the lead assembly 10 may include: an outer protective sheath 11, an inner protective sheath 12, an electromagnetic shielding layer 13, and a wire bundle 14.
- the outer protective sheath 11 is constructed from a tough but flexible material that is preferably wear resistant and/or cut resistant.
- the outer protective sheath 11 may be constructed of polyurethane material. Please note that the materials use to construct the first portion 8 of the lead assembly do not need to be biocompatible and may even be toxic during implant conditions.
- the inner protective sheath 12 provides additional wear resistance.
- the inner protective sheath 12 may function to support the general shape and configuration of the first portion 8.
- the inner protective sheath 12 is flexible yet resistant to wear.
- the inner protective sheath 12 may be constructed of silicone rubber or a similar polymer known as NusilTM. Silicone and NusilTM also have the advantage that they are relatively transparent and enable easy inspection as to the condition and quality of the inner protective sheath 12.
- the electromagnetic shielding layer 13 maybe included within the structure of the first portion 8 of the lead assembly.
- the electromagnetic shielding layer 13 may function to prevent electromagnetic interference from the outside environment interfering with the electric signals being communicated by the lead assembly, when in use.
- the electromagnetic shielding layer 13 is preferably constructed from braided stainless steel and this is because metals generally provide the most efficient electromagnetic shielding. Additionally, stainless steel braid is relatively wear resistant and cut resistant, which prevents accidental breakage by a patient, user or doctor. Also, stainless steel is generally resistant to oxidation or rusting and is therefore preferred for long term applications in vigorous environments and is also suitable for implantation.
- Within the electromagnetic shielding layer 13 may be a wire bundle 14 which contains the wires to act as an electrical conduit for the lead assembly. The wire bundle is generally assembled by inter weaving several insulated wires 15 with each other and a wiring strain relief 17.
- the lead assembly 10 includes three wires, but any number of wires are possible. An increase in the number of wires will increase the overall minimum diameter of the lead assembly, therefore it is preferred to include a minimum amount of insulated wires to provide functionality to the implantable medical device for which the lead assembly is to cooperate.
- the wiring strain relief 17 is constructed from 2 KevlarTM cords with a combined approximate breaking strain of 630N. Additionally, the wires 16 within the wire bundle 14 should be separately insulated preferably using Perfluoroalyoxy ('PFA') insulation 15. A further embodiment is shown in figure 3. This figure depicts the second portion 4 of the lead assembly 10.
- the second portion 4 may include a textured outer surface 19, outer protective layer 21, and a wire bundle 22. Preferably, at least a segment of second portion 4 is covered with a textured outer surface 19.
- the textured outer surface 19 may be constructed of velour or DacronTM. This textured surface may permit a patient's body to ingrow into regions of the lead assembly covered with this textured surface 19. It may also be noted that the textured surface preferably only coats regions of the lead assembly which necessarily must be anchored to the patient's body. Portions of the relatively thin region 20 which extend externally from the patient's body may not require a textured surface for this reason.
- the outer protective layer 21, in this embodiment performs a similar function of the inner protective sheath 12 described in relation to Figure 2.
- the outer protective layer 21 adds further wear resistance, may be flexible, may be substantially biocompatible and may be suitable for implantation.
- the outer protective layer 21 may be constructed of silicone or NusilTM. Beneath the outer protective layer 21 preferably is a wire bundle 22.
- This wire bundle 22 may include: three wires 25 (which are insulated preferably by PFA 23), a wiring strain relief 24, and some silicone or NusilTM to provide dimensional support.
- the wire bundle 22 may be constructed in similar manner to the wire bundle 14 depicted in Figure 2.
- the smaller or thinner diameter of second portion 4 may also increase the anchoring effect of the textured surface, as the thinner region may allow for better tissue integration.
- the smaller or thinner diameter may be accomplished by the removal of outer protective sheath 11 and the shielding layer 13.
- the shielding layer 13 may not be required for communicating electrical signals with a medical device, particularly in cases where the length of the relatively thin region of the lead assembly is relatively short when compared against the exposed regions of the lead assembly 10 which are external to the patient, such as the first portion 8.
- FIG 4 A further embodiment is shown in Figure 4, wherein the lead assembly 10 is implanted within a patient. Please note that similar numerical labelling to Figure 1 has been used in relation to Figure 4.
- the skin layer 26 of a patient is shown with a hole, aperture or exit wound 5.
- the lead assembly 10 passes through the hole 5.
- This embodiment depicts the lead assembly 10 including a relatively thin region 6 and the thicker first portion 8 external of the body of the patient.
- Wires 30 pass through the centre of the lead assembly and allow electrical communication to be achieved between an external device and an internally implanted medical device.
- the internal portion of the lead assembly includes the relatively thin region 6 coated with a textured surface 4.
- the size of the hole 5 is minimised because of the thickness of the relatively thin region 6. This minimisation reduces the probability of infection and promotes wound healing by the patient's body.
- the lead assembly 10 includes a strain terminator mechanism.
- the Figure 5 using similar numerical referencing as Figure 1 & 4, shows the external surface of the patient's skin 26 at a site where the lead assembly 10 exits the body.
- the lead assembly in this embodiment includes of a relatively thin region 6 and a first portion 8, joined by two connectors 33 & 34.
- these connectors mate to form a connection and allow electrical communication of the wires within the lead assembly.
- connectors 33 and 34 are submersible and/or water resistance. This water resistance feature will allow the patient to bath, shower or swim in relative safety in regard to medical device failure or electrocution. This may be achieved by including two 'O' rings within the connectors so as to provide a relatively good seal against water penetration.
- the connectors preferably are made of wear resistance plastic material which is lightweight and unlikely to cause discomfort to the patient. It may also be preferable to allow the connectors to be secured together, when in use, by a screw & thread means.
- the strain terminator mechanism includes: a loop of redundant lead 37 and a lead restraint 35.
- the loop 37 is formed from the relatively thin region 6 of the lead assembly 10 extending from the hole 5 in the patient's skin layer.
- the strain relief mechanism is arranged so that if the lead assembly is accidentally or otherwise pulled, the lead assembly is not pulled from the patient's body.
- the lead assembly may be pulled or jerked suddenly the net result may be to cause serious damage to the patient's skin layer and or internal organs. Additionally, the implanted medical device, which the lead assembly is connected internally to, may also be damaged by such an accident or incident.
- the lead restraint 35 preferably holds the lead assembly and may at the user's discretion release the lead assembly.
- the loop 37 of lead assembly functions to supply additional lead if the lead is pulled through the lead restraint 35.
- the loop 37 serves a backup and provides slack to the lead assembly between the hole 5 and lead restraint 35. Please note that the loop 37 is not required to be in a loop formation, any redundant lead length (such as a coil of lead) between the lead restraint 35 and the hole
- FIG. 6 depicts a preferred lead restraint 35 is depicted.
- This preferred lead restraint 35 includes: a flexible strip 40, interlocking VelcroTM segments 43 & 44 and adhesive 41.
- the lead restraint 35 is constructed by gluing a portion of the flexible strip 40 to the surface skin layer 26 of a patient. This may be accomplished by applying adhesive 41 to the locations depicted in Figure 6. Attached to the opposed surface of flexible strip 40, which was glued to the patient's skin, may be attached at least two segments of interlocking and complementary VelcroTM 43 & 44 regions.
- the relatively thin region 6 of the lead assembly 10 is positioned between the two interlocking layers of VelcroTM 43 & 44.
- the relatively thin region 6 may be secured in place by the lead restraint 35.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12162608.9A EP2505228B1 (en) | 2004-02-04 | 2005-02-02 | An improved percutaneous lead |
EP05700165.3A EP1711221B1 (en) | 2004-02-04 | 2005-02-02 | An improved percutaneous lead |
AU2005209946A AU2005209946B2 (en) | 2004-02-04 | 2005-02-02 | An improved percutaneous lead |
CA2556035A CA2556035C (en) | 2004-02-04 | 2005-02-02 | An improved percutaneous lead |
US10/588,171 US20070129779A1 (en) | 2004-02-04 | 2005-02-02 | Percutaneous lead |
JP2006551679A JP4839224B2 (en) | 2004-02-04 | 2005-02-02 | Transcutaneous lead parts |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004900538 | 2004-02-04 | ||
AU2004900538A AU2004900538A0 (en) | 2004-02-04 | An Improved Percutaneous Lead |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005075017A1 true WO2005075017A1 (en) | 2005-08-18 |
Family
ID=34831679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2005/000135 WO2005075017A1 (en) | 2004-02-04 | 2005-02-02 | An improved percutaneous lead |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070129779A1 (en) |
EP (2) | EP1711221B1 (en) |
JP (1) | JP4839224B2 (en) |
CA (2) | CA2556035C (en) |
WO (1) | WO2005075017A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120063942A1 (en) * | 2006-01-13 | 2012-03-15 | Heartware, Inc. | Shrouded thrust bearings |
EP2530789A3 (en) * | 2009-12-30 | 2013-02-27 | Thoratec Corporation | Mobility-enhancing blood pump system |
US8562508B2 (en) | 2009-12-30 | 2013-10-22 | Thoratec Corporation | Mobility-enhancing blood pump system |
EP2868345A1 (en) * | 2013-10-31 | 2015-05-06 | Berlin Heart GmbH | Electric assembly comprising an implantable cable element |
US9872976B2 (en) | 2010-08-20 | 2018-01-23 | Thoratec Corporation | Assembly and method for stabilizing a percutaneous cable |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7844344B2 (en) | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable lead |
WO2007006080A1 (en) * | 2005-07-12 | 2007-01-18 | Ventracor Limited | Restraining device for a percutaneous lead assembly |
US9044593B2 (en) | 2007-02-14 | 2015-06-02 | Medtronic, Inc. | Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding |
US8483842B2 (en) | 2007-04-25 | 2013-07-09 | Medtronic, Inc. | Lead or lead extension having a conductive body and conductive body contact |
US9037263B2 (en) | 2008-03-12 | 2015-05-19 | Medtronic, Inc. | System and method for implantable medical device lead shielding |
EP2808054B1 (en) | 2009-04-30 | 2019-01-02 | Medtronic Inc. | Grounding of a shield within an implantable medical lead |
EP2575922B1 (en) | 2010-06-07 | 2019-05-22 | Tc1 Llc | Bi-ventricular percutaneous cable |
AU2011336473A1 (en) * | 2010-12-02 | 2013-06-06 | Hemoteq Ag | Surface coating for biomedical implants and electrodes |
US9463317B2 (en) | 2012-04-19 | 2016-10-11 | Medtronic, Inc. | Paired medical lead bodies with braided conductive shields having different physical parameter values |
US9993638B2 (en) | 2013-12-14 | 2018-06-12 | Medtronic, Inc. | Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead |
US9700714B2 (en) | 2013-12-20 | 2017-07-11 | Medtronic, Inc. | Methods and devices for inhibiting tissue growth from restricting a strain relief loop of an implantable medical lead |
EP3171931B1 (en) | 2014-07-23 | 2021-11-10 | Medtronic, Inc. | Methods of shielding implantable medical leads and implantable medical lead extensions |
EP3191175B1 (en) | 2014-07-24 | 2022-03-02 | Medtronic, Inc. | Apparatus for shielding implantable medical leads and lead extensions |
CA3066361A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
CN111556763B (en) | 2017-11-13 | 2023-09-01 | 施菲姆德控股有限责任公司 | Intravascular fluid movement device and system |
EP3746149A4 (en) | 2018-02-01 | 2021-10-27 | Shifamed Holdings, LLC | Intravascular blood pumps and methods of use and manufacture |
WO2021011473A1 (en) | 2019-07-12 | 2021-01-21 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376108A (en) * | 1993-05-20 | 1994-12-27 | Telectronics Pacing Systems, Inc. | Electrode lead anchoring apparatus and method employing dual suture collars |
US5904646A (en) * | 1997-09-08 | 1999-05-18 | Jarvik; Robert | Infection resistant power cable system for medically implanted electric motors |
US20030028148A1 (en) * | 2001-08-01 | 2003-02-06 | Welcon, Inc. | Tubing holder and stabilizer |
WO2004091432A2 (en) * | 2003-04-12 | 2004-10-28 | Medical Research Products-B, Inc. | Percutaneously implantable medical device configured to promote tissue ingrowth |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3699956A (en) * | 1970-10-01 | 1972-10-24 | Tecna Corp | Percutaneous lead device |
US4041936A (en) * | 1975-04-23 | 1977-08-16 | Medical Engineering Corporation | Bronchoscopy tube |
US5144848A (en) * | 1989-11-27 | 1992-09-08 | Olympus Optical Co., Ltd. | Intra-tube traveling apparatus |
US5246014A (en) * | 1991-11-08 | 1993-09-21 | Medtronic, Inc. | Implantable lead system |
US5931850A (en) * | 1992-08-03 | 1999-08-03 | Zadini; Filiberto P. | (Percutaneous cardiac pump for cardiopulmonary resuscitation) cardiac resuscitation device for percutaneous direct cardiac massage |
EP0683926A4 (en) * | 1993-12-14 | 1996-05-15 | Plc Medical Systems Inc | Unitary ecg monitor lead and needle electrode system. |
US5527358A (en) * | 1994-01-21 | 1996-06-18 | Medtronic, Inc. | Temporary medical electrical lead |
US6285910B1 (en) * | 1997-04-21 | 2001-09-04 | Medtronic, Inc. | Medical electrical lead |
US5796044A (en) * | 1997-02-10 | 1998-08-18 | Medtronic, Inc. | Coiled wire conductor insulation for biomedical lead |
JPH10309321A (en) * | 1997-03-11 | 1998-11-24 | San Medical Gijutsu Kenkyusho:Kk | Skin button |
US6324415B1 (en) * | 1997-07-30 | 2001-11-27 | Intermedics Inc. | Cardiac lead with minimized inside diameter of sleeve |
US7887477B2 (en) * | 1999-08-09 | 2011-02-15 | Cardiokinetix, Inc. | Method of improving cardiac function using a porous membrane |
US6374141B1 (en) * | 1999-10-08 | 2002-04-16 | Microhelix, Inc. | Multi-lead bioelectrical stimulus cable |
US6542781B1 (en) * | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
AUPR514201A0 (en) * | 2001-05-21 | 2001-06-14 | Ventrassist Pty Ltd | Staged implantation of ventricular assist devices |
US6606522B2 (en) * | 2001-05-30 | 2003-08-12 | Cardiac Pacemakers, Inc. | Torque mechanism and method for endocardial leads |
US20030144718A1 (en) * | 2002-01-29 | 2003-07-31 | Zeijlemaker Volkert A. | Method and apparatus for shielding coating for MRI resistant electrode systems |
US7158837B2 (en) * | 2002-07-10 | 2007-01-02 | Oscor Inc. | Low profile cardiac leads |
US7158838B2 (en) * | 2003-01-31 | 2007-01-02 | Medtronic, Inc. | Arrangement for implanting a miniaturized cardiac lead having a fixation helix |
-
2005
- 2005-02-02 CA CA2556035A patent/CA2556035C/en not_active Expired - Fee Related
- 2005-02-02 EP EP05700165.3A patent/EP1711221B1/en active Active
- 2005-02-02 EP EP12162608.9A patent/EP2505228B1/en not_active Not-in-force
- 2005-02-02 JP JP2006551679A patent/JP4839224B2/en not_active Expired - Fee Related
- 2005-02-02 CA CA2800131A patent/CA2800131A1/en not_active Abandoned
- 2005-02-02 WO PCT/AU2005/000135 patent/WO2005075017A1/en active Application Filing
- 2005-02-02 US US10/588,171 patent/US20070129779A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376108A (en) * | 1993-05-20 | 1994-12-27 | Telectronics Pacing Systems, Inc. | Electrode lead anchoring apparatus and method employing dual suture collars |
US5904646A (en) * | 1997-09-08 | 1999-05-18 | Jarvik; Robert | Infection resistant power cable system for medically implanted electric motors |
US20030028148A1 (en) * | 2001-08-01 | 2003-02-06 | Welcon, Inc. | Tubing holder and stabilizer |
WO2004091432A2 (en) * | 2003-04-12 | 2004-10-28 | Medical Research Products-B, Inc. | Percutaneously implantable medical device configured to promote tissue ingrowth |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9242032B2 (en) | 2006-01-13 | 2016-01-26 | Heartware, Inc. | Rotary pump with thrust bearings |
US10731652B2 (en) | 2006-01-13 | 2020-08-04 | Heartware, Inc. | Hydrodynamic thrust bearings for rotary blood pump |
US8540477B2 (en) * | 2006-01-13 | 2013-09-24 | Heartware, Inc. | Rotary pump with thrust bearings |
US20120063942A1 (en) * | 2006-01-13 | 2012-03-15 | Heartware, Inc. | Shrouded thrust bearings |
US9777732B2 (en) | 2006-01-13 | 2017-10-03 | Heartware, Inc. | Hydrodynamic thrust bearings for rotary blood pump |
US8562508B2 (en) | 2009-12-30 | 2013-10-22 | Thoratec Corporation | Mobility-enhancing blood pump system |
US10029039B2 (en) | 2009-12-30 | 2018-07-24 | Tc1 Llc | Mobility-enhancing blood pump system |
EP2530789A3 (en) * | 2009-12-30 | 2013-02-27 | Thoratec Corporation | Mobility-enhancing blood pump system |
US10835655B2 (en) | 2009-12-30 | 2020-11-17 | Tc1 Llc | Mobility-enhancing blood pump system |
US9872976B2 (en) | 2010-08-20 | 2018-01-23 | Thoratec Corporation | Assembly and method for stabilizing a percutaneous cable |
WO2015063272A1 (en) * | 2013-10-31 | 2015-05-07 | Berlin Heart Gmbh | Electrical arrangement comprising an implantable cable element |
CN105658275A (en) * | 2013-10-31 | 2016-06-08 | 柏林心脏有限公司 | Electrical arrangement comprising an implantable cable element |
EP2868345A1 (en) * | 2013-10-31 | 2015-05-06 | Berlin Heart GmbH | Electric assembly comprising an implantable cable element |
US9974892B2 (en) | 2013-10-31 | 2018-05-22 | Berlin Heart Gmbh | Electrical arrangement comprising an implantable cable element |
US10195322B2 (en) | 2013-10-31 | 2019-02-05 | Berlin Heart Gmbh | Electrical arrangement comprising an implantable cable element |
Also Published As
Publication number | Publication date |
---|---|
CA2556035C (en) | 2013-04-02 |
CA2800131A1 (en) | 2005-08-18 |
CA2556035A1 (en) | 2005-08-18 |
EP2505228B1 (en) | 2018-11-21 |
JP4839224B2 (en) | 2011-12-21 |
EP1711221B1 (en) | 2019-09-18 |
EP2505228A1 (en) | 2012-10-03 |
EP1711221A1 (en) | 2006-10-18 |
JP2007520283A (en) | 2007-07-26 |
US20070129779A1 (en) | 2007-06-07 |
EP1711221A4 (en) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2505228B1 (en) | An improved percutaneous lead | |
US5904646A (en) | Infection resistant power cable system for medically implanted electric motors | |
EP2252364B1 (en) | Medical electrical lead with proximal armoring | |
US20110152600A1 (en) | Implantable heart assist system | |
EP2164538B1 (en) | Implantable vad with replaceable percutaneous cable | |
EP2146776B1 (en) | Systems for fixating transvenously implanted medical devices | |
US20100106225A1 (en) | Transcutaneous Power And/Or Data Transceiver | |
WO2008106717A1 (en) | Transcutaneous energy transfer system | |
US10518083B2 (en) | Lead with braided reinforcement | |
EP1076584A1 (en) | Connector for implantable medical device | |
US20210170083A1 (en) | Implantable medical device including cable fastener | |
US20090281409A1 (en) | Reinforced medical device | |
AU2005209946B2 (en) | An improved percutaneous lead | |
US11439813B2 (en) | Percutaneous lead | |
US20210290940A1 (en) | Lvad fixation and infection management | |
US20240171009A1 (en) | Transformer implant for inductive power supply to implanted medical device | |
EP4008396A1 (en) | Fastening system for an electrical stimulation generator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006551679 Country of ref document: JP Ref document number: 2556035 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005209946 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005700165 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005209946 Country of ref document: AU Date of ref document: 20050202 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005209946 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005700165 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007129779 Country of ref document: US Ref document number: 10588171 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10588171 Country of ref document: US |